ABIO - ARCA biopharma, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development4,23914,07612,3487,063
Selling General and Administrative3,8794,6364,2654,392
Non Recurring----
Total Operating Expenses8,11818,71216,61311,455
Operating Income or Loss-8,118-18,712-16,613-11,455
Income from Continuing Operations
Total Other Income/Expenses Net31616116910
Earnings Before Interest and Taxes-8,118-18,712-16,613-11,455
Interest Expense-8-6-6-4
Income Before Tax-7,964-18,551-16,444-11,445
Income Tax Expense-31-61--
Minority Interest----
Net Income From Continuing Ops-7,933-18,490-16,444-11,445
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-7,933-18,490-16,444-11,445
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-7,933-18,490-16,444-11,445